1. Deng W#, Yang Z#, Yue H, Ou Y, Hu W*, Sun P*. Disulfiram suppresses NLRP3 inflammasome
activation to treat peritoneal and gouty inflammation[J]. Free Radical Biology and Medicine,
2020(152):8-17.
2. Chen Y#, Chen X#, Liang S, Ou Y, Lin G, Hua L, Wu X, Zhou Y, Liu Z, Cai H, Yang Z, Hu W*, Sun
P*. Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family
pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like
dermatitis in mice[J]. Chemico-Biological Interactions, 2022(365):110122.
3. Liang S#, Yang Z#, Hua L, Chen Y, Zhou Y, Ou Y, Chen X, Yue H, Yang X, Wu X, Hu W*, Sun P*.
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates
imiquimod-induced psoriatic inflammation in mice[J]. European Journal of Pharmacology.
2022(930):175156.
4. Wu X#, Sun P#, Chen X, Hua L, Cai H, Liu Z, Zhang C, Liang S, Chen Y, Wu D, Ou Y, Hu W*,
Yang Z*. Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with
Anti-inflammation Activity[J]. Journal of Medicinal Chemistry. 2022(65):11985-12001.
5. Hao Y, Ou Y, Zhang C, Chen H, Yue H, Yang Z, Zhong X, Hu W*, Sun P*. Seratrodast, a
thromboxane A2 receptor antagonist, inhibits neuronal ferroptosis by promoting GPX4 expression and
suppressing JNK phosphorylation[J]. Brain Research. 2022:148073.
6. Huang X#, Sun P#, Qin Y#, Wang X, Wang M, Lin Y, Zhou R, Hu W, Liu Q*, Yu X*, Qin A*.
Disulfiram attenuates MCMV-Induced pneumonia by inhibition of NF- κ B/NLRP3 signaling pathway in
immunocompromised mice[J]. International Immunopharmacology, 2022(11):108453.
7. Yue H, Yang Z, Ou Y, Liang S, Deng W, Chen H, Zhang C, Hua L, Hu W*, Sun P*. Tanshinones
inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and
gouty inflammation[J]. International Immunopharmacology, 2021(7):107819.
8. Sun P, Yue H, Xing Q, Deng W, Ou Y, Pan G, Zhong X*, Hu W*. Compound AD16 reduces amyloid
plaque deposition and modifies microglia in a transgenic mouse model of Alzheimer's disease[J]. ACS
Pharmacology & Translational Science, 2020, (6):1100-1110.
9. Sun P#, Zhou W#, Yue H, Zhang C, Ou Y, Yang Z*, Hu W*. Compound AD110 acts as therapeutic
management for Alzheimer's disease and stroke in mouse and rat models[J]. ACS Chemical Neuroscience,
2020(6):929-938.
10. Sun P, Ortega G, Tan Y, Hua Q, Riederer PF, Deckert J, Schmitt-Böhrer AG*. Streptozotocin
impairs proliferation and differentiation of adult hippocampal neural stem cells in vitro-correlation with
alterations in the expression of proteins associated with the insulin system[J]. Frontiers in Aging
Neuroscience, 2018(10):145.
代表性成果:
(
Deng, et al.,2020
)